# Long‐term follow‐up of <scp>VIALE‐A</scp>: Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia

*PRI Rank #4 · Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026/rank-4*

| Field | Value |
| --- | --- |
| Rank | #4 |
| 18m citations | 114 |
| Journal | American Journal of Hematology |
| Year | 2024 |
| DOI | 10.1002/ajh.27246 |
| Corresponding authors | Keith W. Pratz |
| Institution | University of Pennsylvania, United States |

**Ranking page:** [Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026](https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026)

**Paper link:** [10.1002/ajh.27246](https://doi.org/10.1002/ajh.27246)

## Topics

Venetoclax · Azacitidine · Acute myeloid leukemia (AML) · chemotherapy-ineligible patients · VIALE-A trial · Overall survival · complete remission with/without blood count recovery · CR/CRi · IDH1/2 mutations · Measurable residual disease (MRD) · thrombocytopenia · neutropenia · Newly diagnosed acute myeloid leukemia · Intensive chemotherapy · long-term follow-up · hazard ratio

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Acute Myeloid Leukemia Research Papers, Class of 2026. https://pri.pepkio.com/top-papers/acute-myeloid-leukemia-research/2026. Accessed 2026-07-31.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```